Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Simpson

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Dermatology and Therapy|December 18, 2025
Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative ReviewJonathan I Silverberg, Eric Simpson, Melinda Gooderham, et al.
Current Medical Research and Opinion|December 19, 2018
Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS)Catherine Foley, Namita Tundia, Eric Simpson, et al.
JAMA Dermatology|February 3, 2021
Shared Decision-making in Dermatology: A Scoping ReviewTessalyn Morrison, Jacob Johnson, Wenelia Baghoomian, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Efalizumab for severe atopic dermatitis: a pilot study in adultsRodd Takiguchi, Susan Tofte, Brenda Simpson, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|December 30, 2021
Validity of the Skindex Mini in Patients With Atopic DermatitisMatthew Philip Dizon, Christina Topham, Dylan Haynes, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|May 12, 2023
The Frequency and Utility of Drug Cessation Trials in Older Adults With Chronic Eczematous Dermatitis of Unknown Etiology: A Retrospective Cohort StudyAmy M Hopkins, Kimberly Lerner, Erin Grinich, et al.
Dermatology and Therapy|September 6, 2025
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic DermatitisEmma Guttman-Yassky, Eric Simpson, Ehsanollah Esfandiari, et al.
Cornea|August 23, 2020
Dupilumab-Associated Ocular Surface Disease: Clinical Characteristics, Treatment, and Follow-UpAustin Bohner, Christina Topham, Jennifer Strunck, et al.
Journal of Biomedical Optics|June 28, 2012
Tri-modal confocal mosaics detect residual invasive squamous cell carcinoma in Mohs surgical excisionsDan Gareau, Anna Bar, Nicholas Snaveley, et al.
Dermatology and Therapy|November 21, 2024
The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic DermatitisChien-Chia Chuang, David M Pariser, Eric Simpson, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Dermatology and Therapy|December 18, 2025
Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative ReviewJonathan I Silverberg, Eric Simpson, Melinda Gooderham, et al.
Current Medical Research and Opinion|December 19, 2018
Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS)Catherine Foley, Namita Tundia, Eric Simpson, et al.
JAMA Dermatology|February 3, 2021
Shared Decision-making in Dermatology: A Scoping ReviewTessalyn Morrison, Jacob Johnson, Wenelia Baghoomian, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Efalizumab for severe atopic dermatitis: a pilot study in adultsRodd Takiguchi, Susan Tofte, Brenda Simpson, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|December 30, 2021
Validity of the Skindex Mini in Patients With Atopic DermatitisMatthew Philip Dizon, Christina Topham, Dylan Haynes, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|May 12, 2023
The Frequency and Utility of Drug Cessation Trials in Older Adults With Chronic Eczematous Dermatitis of Unknown Etiology: A Retrospective Cohort StudyAmy M Hopkins, Kimberly Lerner, Erin Grinich, et al.
Dermatology and Therapy|September 6, 2025
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic DermatitisEmma Guttman-Yassky, Eric Simpson, Ehsanollah Esfandiari, et al.
Cornea|August 23, 2020
Dupilumab-Associated Ocular Surface Disease: Clinical Characteristics, Treatment, and Follow-UpAustin Bohner, Christina Topham, Jennifer Strunck, et al.
Journal of Biomedical Optics|June 28, 2012
Tri-modal confocal mosaics detect residual invasive squamous cell carcinoma in Mohs surgical excisionsDan Gareau, Anna Bar, Nicholas Snaveley, et al.
Dermatology and Therapy|November 21, 2024
The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic DermatitisChien-Chia Chuang, David M Pariser, Eric Simpson, et al.
Pageof 8